Serum Metabolites and Kidney Outcomes: The Atherosclerosis Risk in Communities Study

RATIONALE & OBJECTIVE: Novel metabolite biomarkers of kidney failure with replacement therapy (KFRT) may help identify people at high risk for adverse kidney outcomes and implicated pathways may aid in developing targeted therapeutics. STUDY DESIGN: Prospective cohort. SETTING & PARTICIPANTS...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernard, Lauren, Zhou, Linda, Surapaneni, Aditya, Chen, Jingsha, Rebholz, Casey M., Coresh, Josef, Yu, Bing, Boerwinkle, Eric, Schlosser, Pascal, Grams, Morgan E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420957/
https://www.ncbi.nlm.nih.gov/pubmed/36046612
http://dx.doi.org/10.1016/j.xkme.2022.100522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420957/
https://www.ncbi.nlm.nih.gov/pubmed/36046612
http://dx.doi.org/10.1016/j.xkme.2022.100522

Ejemplares similares